Effect of Alteplase Within 6 Hours of Acute Ischemic Stroke on All-Cause Mortality (Third International Stroke Trial)
How clot composition influences fibrinolysis in the acute phase of stroke: a proteomic study of cerebral thrombi
Reteplase versus Alteplase for Acute Ischemic Stroke
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke
